| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| API & Intermediates |
Now Position:Home > Products > API & Intermediates < Anti-cancer API |
|
| Crizotinib hydrochloride(CAS:1415560-69-8) |
 |
|
|
Product No. |
|
TP1251C |
|
Name |
|
Crizotinib hydrochloride |
|
Synonyms |
|
3-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine hydrochloride |
|
Structure |
|
|
|
Formula |
|
C21H23Cl3FN5O |
|
Weight |
|
486.80 |
|
CAS Number |
|
1415560-69-8 |
|
Purity |
|
>99% | |
|
|
|
|
|
